Curis
John Hohneker is currently a Board Member at Curis. Prior to that, they were the CEO and President at Anokion from January 2018 to February 2021. Before that, they were the CEO at Kanyos Bio from January 2018 to June 2019.
Forma Therapeutics, Inc. from August 2015 to January 2018 where they were President of Research and Development. Evelo Biosciences, Trishula Therapeutics, Inc., Aravive, Inc., and BioTheryX, Inc. are also companies that John has worked for in the past. John has been in the biotech industry for many years and has held various leadership positions.
John Hohneker is a medical doctor who attended Rutgers Robert Wood Johnson Medical School. John also has a bachelor's degree in chemistry from Gettysburg College. John attended Brick Township High School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Curis
Curis is a publicly-traded biotechnology company focused on the development of first-in-class and innovative therapeutics or the treatment of cancer.